Epstein Secrets

Linklaters LLP United Kingdom Geoff Davis Chief Executive Officer White Hat Ventures USA George S. Davis Executive Vice-President and Chief Applied Materials Inc. USA Financial Officer Robed Matthews Davis Vice-President, Public Affairs The Dow Chemical USA Company Sally Davis Chief Executive Officer,

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

Linklaters LLP United Kingdom Geoff Davis Chief Executive Officer White Hat Ventures USA George S. Davis Executive Vice-President and Chief Applied Materials Inc. USA Financial Officer Robed Matthews Davis Vice-President, Public Affairs The Dow Chemical USA Company Sally Davis Chief Executive Officer,

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

ital London School of Economics and Political Science Intel Corporation Frontier Advisory Pty Ltd Sasol Limited Linklaters LLP White Hat Ventures Applied Materials Inc. The Dow Chemical Company BT Group Plc The Dawood Group Tribeca Enterprises LLC The Invus Group LLC JCDecaux SA Cisco Duke University CNN Interna

f Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Director, Marketing Co-Founder and Chief Executive Officer